CS
RVLP

Credit Suisse’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Credit Suisse’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,966
Closed -$84K – 4600
2021
Q2 		$84K Buy
+27,966
New +$85.6K ﹤0.01% 4379

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Credit Suisse's RVLP Position: Q3 2021 in Review

Credit Suisse sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2021, closing a stake of 27,966 shares — an estimated $84K sold.

Credit Suisse first reported a position in RVLP in Q2 2021 and held it in 1 quarter. The position peaked at $84K in Q2 2021. 35 funds tracked by Wall St. Rank hold RVLP as of Q3 2021.

  • Credit Suisse reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Credit Suisse sold 27,966 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2021, an estimated $84K.
  • Credit Suisse first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • Credit Suisse's RVL Pharmaceuticals plc Ordinary Shares position peaked at $84K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.